X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Samrat Pharmachem Ltd.
BSE CODE: 530125   |   NSE CODE: NA   |   ISIN CODE : INE103E01016   |   27-Sep-2024 12:42 Hrs IST
BSE NSE
Rs. 578.00
21.25 ( 3.82% )
 
Prev Close ( Rs.)
556.75
Open ( Rs.)
581.00
 
High ( Rs.)
584.00
Low ( Rs.)
570.00
 
Volume
5622
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
01-Jul-2024 13-Aug-2024 Quarterly Results
28-Mar-2024 30-May-2024 Final Dividend & Audited Results
29-Dec-2023 14-Feb-2024 Quarterly Results
26-Sep-2023 08-Nov-2023 Quarterly Results
30-Jun-2023 14-Aug-2023 Quarterly Results
28-Mar-2023 30-May-2023 Dividend & Audited Results
01-Mar-2023 16-Mar-2023 Inter alia, to consider and approve re-appointment of 3 Executive Directors of the company namely, Mr. Lalit Mehta, Chairman & Managing Director (DIN: 00216681), Mr. Rajesh Mehta, Executive Director (DIN: 00216731) & Mr. Megh Mehta, Executive Director (DIN: 07287394) for a further period of 3 years effective from April 1, 2023 to March 31, 2026, based on the recommendations of the Nomination & Remuneration Committee and to approve the re-appointment through the postal ballot.
30-Sep-2022 14-Nov-2022 Quarterly Results
30-Jun-2022 13-Aug-2022 Quarterly Results
07-Apr-2022 30-May-2022 Dividend & Audited Results
Page 1 of 10
PREV || NEXT